These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 1714571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Construction of a novel artificial-ribozyme-releasing plasmid.
    Taira K, Oda M, Shinshi H, Maeda H, Furukawa K.
    Protein Eng; 1990 Aug; 3(8):733-7. PubMed ID: 2217147
    [Abstract] [Full Text] [Related]

  • 3. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J, Yuyama N, Taira K.
    Nucleic Acids Symp Ser; 1992 Aug; (27):15-6. PubMed ID: 1289797
    [Abstract] [Full Text] [Related]

  • 4. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J, Breaker RR.
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [Abstract] [Full Text] [Related]

  • 5. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R, Montgomery R, Dietz H, Laterra J.
    Methods Mol Biol; 2004 Aug; 252():209-19. PubMed ID: 15017051
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cis-acting ribozymes for the production of RNA in vitro transcripts with defined 5' and 3' ends.
    Avis JM, Conn GL, Walker SC.
    Methods Mol Biol; 2012 Aug; 941():83-98. PubMed ID: 23065555
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. cis-Acting 5' hammerhead ribozyme optimization for in vitro transcription of highly structured RNAs.
    Meyer M, Masquida B.
    Methods Mol Biol; 2014 Aug; 1086():21-40. PubMed ID: 24136596
    [Abstract] [Full Text] [Related]

  • 11. Design and validation of therapeutic hammerhead ribozymes for autosomal dominant diseases.
    Fritz JJ, Gorbatyuk M, Lewin AS, Hauswirth WW.
    Methods Mol Biol; 2004 Aug; 252():221-36. PubMed ID: 15017052
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Gene organization, primary structure and RNA processing analysis of a ribosomal RNA operon in Lactococcus lactis.
    Chiaruttini C, Milet M.
    J Mol Biol; 1993 Mar 05; 230(1):57-76. PubMed ID: 8450551
    [Abstract] [Full Text] [Related]

  • 14. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM, Pietras KM, Shin BJ, Misasi JN.
    Mol Vis; 2002 Apr 08; 8():102-13. PubMed ID: 11961505
    [Abstract] [Full Text] [Related]

  • 15. A ribozyme targeted to RNA polymerase gene of infectious bursal disease virus effectively cleaves and inhibits expression of the viral gene product.
    Akin A, Lin TL, Wu CC.
    Acta Virol; 1999 Dec 08; 43(6):341-7. PubMed ID: 10825922
    [Abstract] [Full Text] [Related]

  • 16. Antitumor activity of systemically delivered ribozymes targeting murine telomerase RNA.
    Nosrati M, Li S, Bagheri S, Ginzinger D, Blackburn EH, Debs RJ, Kashani-Sabet M.
    Clin Cancer Res; 2004 Aug 01; 10(15):4983-90. PubMed ID: 15297398
    [Abstract] [Full Text] [Related]

  • 17. Tetracycline-regulated expression of hammerhead ribozymes in vivo.
    Bowden ET, Riegel AT.
    Methods Mol Biol; 2004 Aug 01; 252():179-94. PubMed ID: 15017049
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The transcriptional terminator sequences downstream of the covR gene terminate covR/S operon transcription to generate covR monocistronic transcripts in Streptococcus pyogenes.
    Chiang-Ni C, Tsou CC, Lin YS, Chuang WJ, Lin MT, Liu CC, Wu JJ.
    Gene; 2008 Dec 31; 427(1-2):99-103. PubMed ID: 18824088
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.